Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis
Sepsis, Septic Shock
About this trial
This is an interventional treatment trial for Sepsis focused on measuring sepsis, apigenin, septic shock
Eligibility Criteria
Inclusion Criteria: age ≥65 years; meeting the diagnostic criteria of the 2016 International Sepsis Guidelines; subjects who voluntarily participated in this study and signed an informed consent form. Exclusion Criteria: patients who are allergic to the study products; patients who are unable to feed via gastrointestinal nutrition tube.
Sites / Locations
- Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
apigenin
sterilized water
Intragastric tube injection of ground apigenin tablet 50 mg with 5 ml of sterilized water + conventional standardized treatment, for 4 consecutive days.
Gastric tube injection of 5 ml of sterilized water for injection + conventional standardized treatment, for 4 consecutive days.